Shortcast: Comparison of subcutaneous and intravenous moss-aGal in Fabry disease mouse model

from JIMD Podcasts · host Journal of Inherited Metabolic Disease

Enzyme Replacement Therapy (ERT) has changed the course of several lysosomal storage disorders but regular, intravenous administration is not without its issues. In this latest Shortcast, Dr Paulina Dabrowska-Schlepp describes her group's work to develop subcutaneous ERT for Fabry Disease. Comparison of efficacy between subcutaneous and intravenous application of moss-aGal in the mouse model of Fabry disease Paulina Dabrowska-Schlepp, et al https://doi.org/10.1002/jmd2.12393

Episode metadata supplied by the publisher feed · Published Oct 9, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Shortcast: Comparison of subcutaneous and intravenous moss-aGal in Fabry disease mouse model

0:00 4:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JIMD Podcasts?

This episode is 4 minutes long.

When was this JIMD Podcasts episode published?

This episode was published on October 9, 2023.

Can I download this JIMD Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!